What You Missed at Asia-Pacific’s Only Drug-Diagnostic Co-Development Forum
您会看到什么 | 見どころ | Apa yang Diharapkan
As APAC grows as an emerging global hub for precision medicine innovation, the 2nd World Companion Diagnostics & Liquid Biopsy Summit APAC spotlighted the region’s latest advances in biomarker-guided trials, CDx regulation, and cross-border co-development to accelerate access to precision therapies across oncology and beyond. Uniting local and global decision makers from biopharma, healthcare institutions, regulatory agencies, diagnostic developers, and testing labs, this summit empowered scalable, timely, and equitable diagnostic access for diverse patient populations across the region.
2025 Event Highlights
Advanced Novel Biomarker Discovery & Validation
Improved patient selection and monitoring across solid and hematologic tumors with ctDNA, MRD and CTCs to organoid models and multiplex assays with AstraZeneca, Johnson & Johnson and OBI Pharma
Optimized Biomarker-Driven Trials
Navigated regional and global biomarker-driven trials with centralized and decentralized vendor networks to support both localized patient recruitment and global co-development success for CDx programs with Chugai Pharmaceuticals and Gilead Sciences
Fuelled Precision Medicine Beyond Oncology
The summit uncovered precision medicine applications in neurologic, chronic and rare diseases with gene panels, digital and multiplex biomarkers for earlier detection, improved stratification, and enhanced patient access to targeted therapies with FIND and Heidelberg University
De-Risked Regulatory Filing & Launch
Decoded IVD regulation and commercialization across fragmented APAC jurisdictions and shifting global LDT and IVDR compliance through proactive engagement with regional competent and notified bodies to unlock timely and equitable access with TÜV SÜD and ARPA
Explore the 2025 Full Event Guide
议程 | 議題 | Agenda
- Free* to Attend for Biopharma & Academia
- Asia-Pacific’s Only Biomarker & Companion Diagnostic Forum
- Solid Tumor & Liquid Biopsy Biomarker Strategies
- Oncology, Neurological & Rare Disease Case Studies
- Exclusive Networking & Partnerships with Global Decision Makers
Attending Companies Included:
Explore the 2025 Agenda
Gain first-hand insights into the latest regional and global breakthroughs in biomarkers, clinical development, and CDx approvals. Explore APAC’s most innovative precision medicine advances through a packed agenda of expert-led sessions and exclusive drug-diagnostic partnership discussions
Partner With Us in 2026
Position your brand alongside leading global and APAC-local CDx and IVD innovators to stay at the forefront of precision medicine partnerships and commercialization across Asia-Pacific
Join Biopharma Experts
Join the region’s only precision medicine community for dynamic and high-impact conversations across diverse precision medicine therapy areas and modalities